Dow Futures Steady as Indices Extend Gains Amid Choppy Trade By Investing.com



© Reuters.

By Oliver Gray 

Investing.com – U.S. stock futures were  little changed during Thursday’s evening deals, after major benchmark indices extended gains for the second consecutive session as investors digested Fed Chair Powell’s latest comments on inflation.

By 7:05pm ET (11:05pm GMT) were little changed while and added 0.1% and 0.2% respectively

In extended deals, DocuSign Inc (NASDAQ:) added 18% after Q2 EPS of $0.44 versus $0.42 expected on revenues of $622.2 million versus $602 million expected.

American Outdoor Brands Inc (NASDAQ:) dipped 6% after the company Q2 EPS of $0.01, worse than $0.07 expected, while revenue came in at $43.7 million versus $44.48 million expected.

National Beverage (NASDAQ:) dropped 0.8% after Q2 EPS of $0.38 versus $0.52 expected on revenues of $318.1 million versus $331.97 million expected.

Zscaler (NASDAQ:) lifted 11.8% after Q4 EPS of $0.25, above expectations of $0.21, while revenue came in at $318.1 million versus $305.43 million expected.

Limoneira Co (NASDAQ:) added 10.2% as the company Q3 EPS of $0.41, above analyst estimates of $0.24, while revenue was reported at $58.9 million versus $51.39 million expected.

Zumiez, Inc. (NASDAQ:) dropped 10.3%, Q2 EPS of $0.16, below expectations of $0.47, while revenue came in at $220 million versus $232.71 million.

Smith & Wesson Brands Inc (NASDAQ:) fell 5.5% as the company Q1 EPS of $0.11 versus $0.57 expected on revenues of $190.2 million versus $167.68 million expected.

During Thursday’s session, the jumped 193.24 points, or 0.61%, to close at 31,774.52. The rose 0.66% to 4,006.18, and the advanced 0.60% to 11,862.13.

On the bond markets, rates were at 3-month highs of 3.323%.



Read More: Dow Futures Steady as Indices Extend Gains Amid Choppy Trade By Investing.com

2022-09-08 16:12:00

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More